Bios Fund II, LP

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2025-05-27	2025-05-27	Lantern Pharma Inc. (LTRN)	PrS Proposed sale	38,353 358.34 US$3,697,764	38,353	358.34	US$3,697,764
2024-04-26	2024-04-29	Lantern Pharma Inc. (LTRN)	PrS Proposed sale	58,937 264.17 US$1,165,737	58,937	264.17	US$1,165,737
2024-02-28	2024-02-27	Lantern Pharma Inc. (LTRN)	PrS Proposed sale	72,870 280.08 US$3,593,572	72,870	280.08	US$3,593,572